跳至主要内容
临床试验/NCT06268522
NCT06268522已完成不适用

Adjunctive Mindfulness During Opioid Tapering for Patients With Chronic Pain

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2024年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
121
试验地点
1
主要终点
Pain Interference

研究概览

简要总结

This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age>18yo
  • Chronic Low Back Pain as seen on medical history as well as score of >3 on pain visual analog scale (VAS) at the start of experimental sessions.
  • receiving prescription opioids for three or more months and planning to start tapering their opioids with their provider.
  • willing to be randomized to one of the two behavioral treatment. Patients referred or self-referred to the study from an outside clinic will also be able to participate (we will be in contact with their prescribing provider)
  • able and willing to perform/tolerate pain procedures (e.g., QST)
  • able to communicate fluently in English
  • able to use a smartphone or laptop for the virtual therapy program

排除标准

  • Current illicit substance use (e.g marijuana use will be exempted) at screening or during trial as verified by urine toxicology screen and/or self-report for all participants;
  • Medical condition known to influence QST or participation in the MORE intervention; serious psychiatric condition;
  • regular meditation practice
  • cognitive impairment
  • pregnancy
  • lack of English fluency
  • severe OUD
  • inability to provide informed consent.

研究组 & 干预措施

Mindfulness-Oriented Recovery Enhancement: (MORE) group

Experimental

干预措施: Mindfulness-Oriented Recovery Enhancement: (MORE) group (Behavioral)

Psychoeducation

Placebo Comparator

干预措施: Psychoeducation (Behavioral)

结局指标

主要结局

Pain Interference

时间窗: Baseline, 8 weeks, 3 month and 6 month follow up

assessed by the Brief pain interventory

Opioid Dose

时间窗: Baseline, 8 weeks, 3 month and 6 month follow up

assessed through their medical record

次要结局

  • Opioid Misuse(Baseline, 8 weeks, 3 month and 6 month follow up)
  • Opioid Craving(Baseline,8 weeks, 3 month and 6 month follow up)
  • Opioid Withdrawal(Baseline, 8 weeks, 3 month and 6 month follow up)
  • Pain Intensity(Baseline, 8 weeks, 3 month and 6 month follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asimina Lazaridou, PhD

Instructor

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验